Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Apollo Commercial Real Estate Finance, Inc. (ARI) Stock Forecast 2025 - AI Price Prediction & Analysis

Apollo Commercial Real Estate Finance, Inc. (ARI) AI Stock Price Forecast & Investment Analysis

Apollo Commercial Real Estate Finance, Inc. Stock Price Chart and Technical Analysis

Loading Apollo Commercial Real Estate Finance, Inc. interactive price chart and technical analysis...

Apollo Commercial Real Estate Finance, Inc. (ARI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Apollo Commercial Real Estate Finance, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Apollo Commercial Real Estate Finance, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Apollo Commercial Real Estate Finance, Inc.: Apollo Commercial Real Estate Finance, Inc. operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

Apollo Commercial Real Estate Finance, Inc. (Stock Symbol: ARI) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Apollo Commercial Real Estate Finance, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Commercial Real Estate Finance, Inc.: With $278M in annual revenue and -39.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $278 million generating a -39.4% net profit margin .

Market Capitalization: $1379 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 7.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Apollo Commercial Real Estate Finance, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Apollo Commercial Real Estate Finance, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Apollo Commercial Real Estate Finance, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Apollo Commercial Real Estate Finance, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Apollo Commercial Real Estate Finance, Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

Apollo Commercial Real Estate Finance, Inc. strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $205 million annually, complemented by impressive -40.0% year-over-year cash flow growth.

Apollo Commercial Real Estate Finance, Inc. (ARI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Apollo Commercial Real Estate Finance, Inc. stock analysis.

Loading Apollo Commercial Real Estate Finance, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Apollo Commercial Real Estate Finance, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Apollo Commercial Real Estate Finance, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Apollo Commercial Real Estate Finance, Inc.: With a P/E ratio of -9.01, the market sees the stock as potentially undervalued.

P/E Ratio -9.01x
P/B Ratio 0.75x
Market Cap $1379M
Dividend Yield 10.08%
EPS $-0.15
Book Value/Share $13.29
Revenue/Share $2.01
FCF/Share $1.10
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Apollo Commercial Real Estate Finance, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Apollo Commercial Real Estate Finance, Inc.: An ROE of 7.2% indicates room for improvement in shareholder value creation.

ROE 7.2%
ROA 2.0%
Net Margin -39.4%
EBT Margin 67.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Apollo Commercial Real Estate Finance, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Apollo Commercial Real Estate Finance, Inc.:

D/E Ratio 0.89x
Financial Leverage 3.91x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Apollo Commercial Real Estate Finance, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Apollo Commercial Real Estate Finance, Inc.: Free cash flow of $205M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $205M
Free Cash Flow $205M
OCF Growth YoY -40.0%
FCF Growth YoY -40.0%
FCF/Sales 77.2%
CapEx/Sales 0.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Apollo Commercial Real Estate Finance, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Apollo Commercial Real Estate Finance, Inc.: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Understanding Financial Statement Data

What these metrics mean: Key figures from Apollo Commercial Real Estate Finance, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Apollo Commercial Real Estate Finance, Inc.: With annual revenue of $278M, Apollo Commercial Real Estate Finance, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $278M
SG&A Expense $25M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 2%
Total Liabilities 74%
Accounts Receivable 1%
Dividend & Shareholder Information
Dividends Per Share $1.00
Payout Ratio -0.6%
Shares Outstanding 139M
Growth Metrics (YoY)
EPS Growth -9.7%

Latest Apollo Commercial Real Estate Finance, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Apollo Commercial Real Estate Finance, Inc. (ARI) stock price and investment outlook.

📰 We are currently updating our news feed for Apollo Commercial Real Estate Finance, Inc.. Check back soon for the latest market analysis and company updates.

Apollo Commercial Real Estate Finance, Inc. Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of Apollo Commercial Real Estate Finance, Inc. against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1185M 12.6x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $2264M 10.6x 0.8x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3500M 16.4x 1.2x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3471M 16.2x 1.2x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4356M 20.4x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $138M 6.4x 0.3x
ACRE Unlock Forecast - 30 Days FREE Trial $246M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 8.6x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $155M 7.2x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8250M 44.4x 1.5x
ADC-PA Unlock Forecast - 30 Days FREE Trial $1981M 10.7x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $10334M 27.3x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $25720M 68.0x 2.5x
AGNCM Unlock Forecast - 30 Days FREE Trial $25584M 67.7x 2.5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26490M 70.1x 2.6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26220M 69.4x 2.5x
AGNCP Unlock Forecast - 30 Days FREE Trial $25834M 68.3x 2.5x
AHR Unlock Forecast - 30 Days FREE Trial $6766M x 2.8x
AHT Unlock Forecast - 30 Days FREE Trial $30M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $112M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $97M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $83M x x
AIV Unlock Forecast - 30 Days FREE Trial $765M -6.0x 8.3x
ALEX Unlock Forecast - 30 Days FREE Trial $1214M 15.6x 1.2x
ALX Unlock Forecast - 30 Days FREE Trial $1203M 32.2x 8.3x
AMT Unlock Forecast - 30 Days FREE Trial $89567M 69.3x 24.1x
APLE Unlock Forecast - 30 Days FREE Trial $2740M 15.1x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $12814M 55.8x 0.8x
ARI Unlock Forecast - 30 Days FREE Trial $1379M -9.0x 0.8x
ARR Unlock Forecast - 30 Days FREE Trial $1363M -6.0x 0.8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1887M x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $26264M 22.6x 2.2x
BDN Unlock Forecast - 30 Days FREE Trial $641M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $732M 17.0x 2.3x
BFS-PD Unlock Forecast - 30 Days FREE Trial $545M 12.7x 1.7x
BFS-PE Unlock Forecast - 30 Days FREE Trial $564M 13.1x 1.8x
BHM Unlock Forecast - 30 Days FREE Trial $41M 15.0x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $180M -3.1x 0.8x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1056M x 4.7x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1376M x 6.1x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0.6x
BNL Unlock Forecast - 30 Days FREE Trial $3530M 35.7x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $669M -6.6x 0.7x
BRT Unlock Forecast - 30 Days FREE Trial $268M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $8210M 24.5x 2.8x
BXP Unlock Forecast - 30 Days FREE Trial $11147M 2258.8x 2.1x
CBL Unlock Forecast - 30 Days FREE Trial $904M 13.8x 3.1x
CCI Unlock Forecast - 30 Days FREE Trial $42404M 36.6x 6.0x
CDP Unlock Forecast - 30 Days FREE Trial $3160M 21.0x 2.1x
CDR-PB Unlock Forecast - 30 Days FREE Trial $254M 46.0x 11.3x
CDR-PC Unlock Forecast - 30 Days FREE Trial $228M 41.3x 10.2x
CHCT Unlock Forecast - 30 Days FREE Trial $393M -220.9x 0.9x
CHMI Unlock Forecast - 30 Days FREE Trial $87M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $800M x 3.5x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $859M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $657M x 0.9x
CIM Unlock Forecast - 30 Days FREE Trial $1032M 5.4x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2054M 10.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2069M 10.7x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1783M 9.3x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1954M 10.1x 0.7x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1821M 9.5x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1941M 10.1x 0.7x
CIO Unlock Forecast - 30 Days FREE Trial $281M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1006M x 1.6x
CLDT Unlock Forecast - 30 Days FREE Trial $309M 32.7x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1027M 108.6x 1.4x
CMCT Unlock Forecast - 30 Days FREE Trial $5M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $991M x 0.6x
COLD Unlock Forecast - 30 Days FREE Trial $3884M -26.5x 1.3x
CPT Unlock Forecast - 30 Days FREE Trial $10888M 69.8x 2.4x
CSR Unlock Forecast - 30 Days FREE Trial $1010M -74.6x 1.4x
CTO Unlock Forecast - 30 Days FREE Trial $518M 41.8x 0.9x
CTO-PA Unlock Forecast - 30 Days FREE Trial $687M x 1.2x
CTRE Unlock Forecast - 30 Days FREE Trial $6745M 30.7x 2.0x
CUBE Unlock Forecast - 30 Days FREE Trial $9546M 25.5x 3.4x
CUZ Unlock Forecast - 30 Days FREE Trial $4468M 74.2x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $1899M 18.3x 1.3x
DEI Unlock Forecast - 30 Days FREE Trial $2263M 60.0x 1.1x
DHC Unlock Forecast - 30 Days FREE Trial $991M -1.7x 0.5x
DHCNI Unlock Forecast - 30 Days FREE Trial $4140M -10.4x 2.2x
DLR Unlock Forecast - 30 Days FREE Trial $58792M 42.5x 2.6x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7713M 5.6x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8327M 6.0x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7536M 5.5x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $12821M 77.7x 1.6x
DRH Unlock Forecast - 30 Days FREE Trial $1568M 23.1x 1.0x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5206M 76.7x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1677M 25.7x 2.9x
DX-PC Unlock Forecast - 30 Days FREE Trial $3201M 48.9x 5.5x
EARN Unlock Forecast - 30 Days FREE Trial $193M -11.6x 0.8x
EGP Unlock Forecast - 30 Days FREE Trial $9476M 40.1x 2.8x
ELME Unlock Forecast - 30 Days FREE Trial $1474M -114.5x 1.4x
ELS Unlock Forecast - 30 Days FREE Trial $11895M 23.8x 6.9x
EPR Unlock Forecast - 30 Days FREE Trial $4162M 23.2x 2.0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2358M 13.1x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1587M 8.8x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6041M 27.0x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $79542M 80.0x 5.7x
ESS Unlock Forecast - 30 Days FREE Trial $16590M 20.7x 2.9x
EXR Unlock Forecast - 30 Days FREE Trial $32262M 33.1x 2.3x
FBRT Unlock Forecast - 30 Days FREE Trial $882M 8.1x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1838M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2488M 23.5x 1.7x
FPI Unlock Forecast - 30 Days FREE Trial $453M 6.5x 452758.4x
FR Unlock Forecast - 30 Days FREE Trial $7298M 30.8x 2.8x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8456M 24.4x 2.6x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1820M 5.3x 0.6x
FSP Unlock Forecast - 30 Days FREE Trial $143M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $287M x 0.8x
GIPR Unlock Forecast - 30 Days FREE Trial $7M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $12622M 17.6x 2.8x
GMRE Unlock Forecast - 30 Days FREE Trial $2137M 207.7x 4.3x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1671M 162.4x 3.3x
GPMT Unlock Forecast - 30 Days FREE Trial $122M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $953M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2564M x 2.9x
HIW Unlock Forecast - 30 Days FREE Trial $3241M 24.7x 1.4x
HST Unlock Forecast - 30 Days FREE Trial $11131M 16.9x 1.7x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $197M 17.4x 0.8x
IHT Unlock Forecast - 30 Days FREE Trial $12M -57.7x 3.2x
ILPT Unlock Forecast - 30 Days FREE Trial $366M -2.3x 0.7x
IMPM Unlock Forecast - 30 Days FREE Trial $4M x x
INN Unlock Forecast - 30 Days FREE Trial $580M 67.3x 0.7x
INN-PE Unlock Forecast - 30 Days FREE Trial $2080M 241.6x 2.3x
INN-PF Unlock Forecast - 30 Days FREE Trial $3180M 369.2x 3.6x
IOR Unlock Forecast - 30 Days FREE Trial $72M 16.8x 0.6x
IRT Unlock Forecast - 30 Days FREE Trial $3746M 134.9x 1.1x
IVR Unlock Forecast - 30 Days FREE Trial $479M 11.8x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1627M 40.1x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2149M 19.2x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1256M -11.3x 0.7x
KBSR Unlock Forecast - 30 Days FREE Trial $45M x 0.2x
KIM Unlock Forecast - 30 Days FREE Trial $14634M 24.5x 1.4x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14248M 23.8x 1.4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $14648M 24.5x 1.4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39332M 65.8x 3.7x
KRC Unlock Forecast - 30 Days FREE Trial $4767M 21.7x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $567M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1412M x 1.1x
KRG Unlock Forecast - 30 Days FREE Trial $4837M 25.9x 1.5x
LAMR Unlock Forecast - 30 Days FREE Trial $12541M 28.5x 13.9x
LFT Unlock Forecast - 30 Days FREE Trial $93M 6.5x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1061M 74.5x 4.6x
LINE Unlock Forecast - 30 Days FREE Trial $9387M x 1.1x
LOAN Unlock Forecast - 30 Days FREE Trial $60M 10.9x 1.4x
LTC Unlock Forecast - 30 Days FREE Trial $1595M 19.2x 1.7x
LXP Unlock Forecast - 30 Days FREE Trial $2749M 31.4x 1.3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14199M 162.3x 6.9x
MAA Unlock Forecast - 30 Days FREE Trial $15387M 26.9x 2.6x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6515M 11.4x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4309M -64.7x 1.7x
MDV Unlock Forecast - 30 Days FREE Trial $165M -24.6x 1.0x
MDV-PA Unlock Forecast - 30 Days FREE Trial $290M x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $930M 7.2x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2597M 20.2x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2616M 20.4x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2132M 16.6x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2535M 19.7x 1.4x
MITN Unlock Forecast - 30 Days FREE Trial $753M 16.2x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $755M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $209M 4.5x 0.4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $666M 14.4x 1.2x
MITT-PB Unlock Forecast - 30 Days FREE Trial $631M 13.6x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $747M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $84M x 1.3x
MPW Unlock Forecast - 30 Days FREE Trial $3076M -1.3x 0.6x
NHI Unlock Forecast - 30 Days FREE Trial $3381M 23.7x 2.3x
NLCP Unlock Forecast - 30 Days FREE Trial $265M 10.2x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $429M x 0.9x
NNN Unlock Forecast - 30 Days FREE Trial $7957M 20.3x 1.8x
NREF Unlock Forecast - 30 Days FREE Trial $239M 2.8x 1.8x
NREF-PA Unlock Forecast - 30 Days FREE Trial $414M 4.8x 3.1x
NTST Unlock Forecast - 30 Days FREE Trial $1589M 1247.7x 1.2x
NXDT Unlock Forecast - 30 Days FREE Trial $161M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $672M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $781M 16.6x 2.3x
O Unlock Forecast - 30 Days FREE Trial $54802M 59.8x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $143M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $928M 144.8x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $2915M 27.1x 5.4x
PCH Unlock Forecast - 30 Days FREE Trial $3287M 78.9x 1.7x
PCOK Unlock Forecast - 30 Days FREE Trial $5M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1264M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2258M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2292M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2281M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2066M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4728M 68.7x 2.1x
PINE Unlock Forecast - 30 Days FREE Trial $196M 169.3x 0.9x
PKST Unlock Forecast - 30 Days FREE Trial $462M -3.7x 0.6x
PLD Unlock Forecast - 30 Days FREE Trial $115151M 33.4x 2.2x
PLDGP Unlock Forecast - 30 Days FREE Trial $51710M 15.0x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1014M 9.6x 0.5x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2073M 19.7x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2078M 19.8x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1629M 15.5x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2228M 21.2x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2229M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2222M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $53964M 29.8x 5.8x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3946M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3867M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4272M 2.4x 0.5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3672M 2.0x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3522M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3554M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3436M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3086M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2892M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2890M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $3023M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2971M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2973M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3086M 1.7x 0.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $89M x 15.1x
RC Unlock Forecast - 30 Days FREE Trial $532M -13.0x 0.3x
RCB Unlock Forecast - 30 Days FREE Trial $4028M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4054M -45.2x 2.2x
RCD Unlock Forecast - 30 Days FREE Trial $3987M x 2.2x
RC-PC Unlock Forecast - 30 Days FREE Trial $2742M x 1.5x
RC-PE Unlock Forecast - 30 Days FREE Trial $2483M x 1.4x
REXR Unlock Forecast - 30 Days FREE Trial $10206M 32.2x 1.2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5420M 17.1x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5278M 16.6x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $5560M 20.8x 7.0x
RITM Unlock Forecast - 30 Days FREE Trial $5674M 7.1x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $13581M 16.9x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13517M 16.8x 1.7x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13194M 16.4x 1.7x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13072M 16.3x 1.7x
RLJ Unlock Forecast - 30 Days FREE Trial $1038M 18.0x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3802M 65.8x 1.7x
SAFE Unlock Forecast - 30 Days FREE Trial $1108M 10.8x 0.5x
SBAC Unlock Forecast - 30 Days FREE Trial $21220M 24.2x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4268M 23.4x 1.6x
SELF Unlock Forecast - 30 Days FREE Trial $56M 22.7x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $155M 10.0x 0.6x
SITC Unlock Forecast - 30 Days FREE Trial $453M 1.2x 0.9x
SKT Unlock Forecast - 30 Days FREE Trial $3659M 38.7x 5.8x
SLG Unlock Forecast - 30 Days FREE Trial $3801M -33.2x 1.0x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1541M x 0.4x
SQFT Unlock Forecast - 30 Days FREE Trial $50M 1.2x 1.4x
SQFTP Unlock Forecast - 30 Days FREE Trial $139M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7021M 30.0x 2.0x
STLY Unlock Forecast - 30 Days FREE Trial $24M 37.8x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $151M 25.4x 9.8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6262M 16.9x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15567M 12.1x 2.1x
SUNS Unlock Forecast - 30 Days FREE Trial $126M 12.6x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $379M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $388M 58.8x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $201M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $562M x 3.3x
TRTX Unlock Forecast - 30 Days FREE Trial $681M 10.1x 0.6x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1390M 20.7x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $1002M -55.6x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2702M x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2435M x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2369M x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2469M x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11897M 90.2x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $500M 27.9x 3.0x
UMH Unlock Forecast - 30 Days FREE Trial $1206M 39.5x 1.3x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63.1x 2.1x
VICI Unlock Forecast - 30 Days FREE Trial $32473M 11.8x 1.2x
VNO Unlock Forecast - 30 Days FREE Trial $7586M 8.7x 1.3x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3466M 4.0x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3476M 4.0x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3478M 4.0x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2865M 3.3x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $15661M 17.9x 2.6x
VRE Unlock Forecast - 30 Days FREE Trial $1363M -32.8x 1.3x
VTR Unlock Forecast - 30 Days FREE Trial $31593M 165.2x 2.7x
WELL Unlock Forecast - 30 Days FREE Trial $114454M 101.3x 3.2x
WHLR Unlock Forecast - 30 Days FREE Trial $4M 1.7x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $39M 17.5x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $126M 56.0x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $5M 2.0x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14991M 44.7x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $608M 18.0x 1.4x
WY Unlock Forecast - 30 Days FREE Trial $17071M 61.2x 1.8x

Frequently Asked Questions - Apollo Commercial Real Estate Finance, Inc. Stock Forecast

How accurate are Apollo Commercial Real Estate Finance, Inc. stock predictions?

Our AI model demonstrates 68% historical accuracy for ARI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Apollo Commercial Real Estate Finance, Inc. stock price forecasts?

Our analysis considers Apollo Commercial Real Estate Finance, Inc.'s financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Apollo Commercial Real Estate Finance, Inc. a good investment in 2025?

Based on our AI analysis, Apollo Commercial Real Estate Finance, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Apollo Commercial Real Estate Finance, Inc. forecasts updated?

Apollo Commercial Real Estate Finance, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Apollo Commercial Real Estate Finance, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Apollo Commercial Real Estate Finance, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...